A potential explanation for this result is that the survival of the NHF1TRAIL cells in the brain without CLIP is too short to provide a potent enough dose to kill the tumor cells, leading to eventual recurrence as the tumor develops TRAIL‐resistance mechanisms. The gene discussed is TNFSF10; the disease is neoplasm.